Literature DB >> 24836851

Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones.

Cheryl Dambrot1, Henk P J Buermans2, Eszter Varga3, Georgios Kosmidis4, Karin Langenberg5, Simona Casini4, David A Elliott6, Andras Dinnyes3, Douwe E Atsma7, Christine L Mummery8, Stefan R Braam9, Richard P Davis10.   

Abstract

Recent methodological advances have improved the ease and efficiency of generating human induced pluripotent stem cells (hiPSCs), but this now typically results in a greater number of hiPSC clones being derived than can be wholly characterized. It is therefore imperative that methods are developed which facilitate rapid selection of hiPSC clones most suited for the downstream research aims. Here we describe a combination of procedures enabling the simultaneous screening of multiple clones to determine their genomic integrity as well as their cardiac differentiation potential within two weeks of the putative reprogrammed colonies initially appearing. By coupling splinkerette-PCR with Ion Torrent sequencing, we could ascertain the number and map the proviral integration sites in lentiviral-reprogrammed hiPSCs. In parallel, we developed an effective cardiac differentiation protocol that generated functional cardiomyocytes within 10 days without requiring line-specific optimization for any of the six independent human pluripotent stem cell lines tested. Finally, to demonstrate the scalable potential of these procedures, we picked 20 nascent iPSC clones and performed these independent assays concurrently. Before the clones required passaging, we were able to identify clones with a single integrated copy of the reprogramming vector and robust cardiac differentiation potential for further analysis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyocytes; Cell differentiation; High-throughput DNA sequencing; Human induced pluripotent stem cell

Mesh:

Year:  2014        PMID: 24836851     DOI: 10.1016/j.yexcr.2014.05.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Improved Atrial Differentiation of Human Pluripotent Stem Cells by Activation of Retinoic Acid Receptor Alpha (RARα).

Authors:  Verena Schwach; Carla Cofiño-Fabres; Simone A Ten Den; Robert Passier
Journal:  J Pers Med       Date:  2022-04-13

2.  Acetaminophen induces JNK/p38 signaling and activates the caspase-9-3-dependent cell death pathway in human mesenchymal stem cells.

Authors:  Giou-Teng Yiang; Yung-Lung Yu; Ko-Ting Lin; Jen-Ni Chen; Wei-Jung Chang; Chyou-Wei Wei
Journal:  Int J Mol Med       Date:  2015-06-19       Impact factor: 4.101

3.  Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling.

Authors:  Asifiqbal Kadari; SubbaRao Mekala; Nicole Wagner; Daniela Malan; Jessica Köth; Katharina Doll; Laura Stappert; Daniela Eckert; Michael Peitz; Jan Matthes; Philipp Sasse; Stefan Herzig; Oliver Brüstle; Süleyman Ergün; Frank Edenhofer
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

4.  A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.

Authors:  Luca Sala; Zhiyi Yu; Dorien Ward-van Oostwaard; Jacobus Pd van Veldhoven; Alessandra Moretti; Karl-Ludwig Laugwitz; Christine L Mummery; Adriaan P IJzerman; Milena Bellin
Journal:  EMBO Mol Med       Date:  2016-09-01       Impact factor: 12.137

5.  Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs).

Authors:  Luca Sala; Dorien Ward-van Oostwaard; Leon G J Tertoolen; Christine L Mummery; Milena Bellin
Journal:  J Vis Exp       Date:  2017-05-12       Impact factor: 1.355

6.  Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and Müller Glia Are Targets of AAV5.

Authors:  Peter M Quinn; Thilo M Buck; Aat A Mulder; Charlotte Ohonin; C Henrique Alves; Rogier M Vos; Monika Bialecka; Tessa van Herwaarden; Elon H C van Dijk; Mays Talib; Christian Freund; Harald M M Mikkers; Rob C Hoeben; Marie-José Goumans; Camiel J F Boon; Abraham J Koster; Susana M Chuva de Sousa Lopes; Carolina R Jost; Jan Wijnholds
Journal:  Stem Cell Reports       Date:  2019-04-04       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.